The CATALYST Study

TerminatedOBSERVATIONAL
Enrollment

6,069

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

January 27, 2025

Study Completion Date

January 27, 2025

Conditions
HIV Prevention
Trial Locations (28)

Unknown

Chulaimbo sub-country hospital, Kisumu

Migosi Health, Kisumu

Likoni Sub-country hospital, Mombasa

Tudor sub-country hospital, Mombasa

Bar Hostess Empowerment & Support Programme (BHESP) Drop-In Centre, Nairobi

Mukuru Public Health Centre, Nairobi

Sefika, Maseru

Scott Hospital, Morija

Berea, Teyateyaneng

Phomolong Clinic, Hennenman

FSW Esselen Street, Johannesburg

TG Esselen Street, Johannesburg

Hani Park Clinic, Welkom

Matjhabeng Clinic, Welkom

Welkom Clinic, Welkom

Gulu RRH, Gulu

Bufunda HC III, Ibanda

Kitgum Hospital, Kitgum

Namakwekwe HC III, Mbale

Mbarara HC IV, Mbarara

Bison HCCIII, Tororo

Malaba HC III, Tororo

Beitbridge Wellness Clinic, Beitbridge

Cowdray Park Clinic, Bulawayo

Plumtree District Hospital, Bulawayo

SHAZ! Hub (Citimed Hopstial), Chitungwiza

Runyararo Clinic, Masvingo

Ngundu Rural Health Center, Ngundu

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Wits Reproductive Health and HIV Institute

OTHER

collaborator

LVCT Health

OTHER

collaborator

Pangaea Zimbabwe Aids Trust

OTHER

collaborator

Jhpiego

OTHER

collaborator

United States Agency for International Development (USAID)

FED

lead

FHI 360

OTHER